Literature DB >> 26475461

Pulmonary Carcinosarcoma Arising in the Framework of an Idiopathic Pulmonary Fibrosis.

Filippo Lococo, Fabrizio Luppi, Stefania Cerri, Gloria Montanari, Alessandro Stefani, Giulio Rossi.   

Abstract

Entities:  

Mesh:

Year:  2016        PMID: 26475461     DOI: 10.1007/s00408-015-9818-3

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


× No keyword cloud information.
  4 in total

1.  Characteristics and Prognostic Analysis of 69 Patients With Pulmonary Sarcomatoid Carcinoma.

Authors:  Yongbin Lin; Han Yang; Qingqing Cai; Daofeng Wang; Huilan Rao; Suxia Lin; Hao Long; Jianhua Fu; Lanjun Zhang; Peng Lin; Guangchuan Xu; Tiehua Rong; Xiaoxing Xiong; Guowei Ma; Ying Liang
Journal:  Am J Clin Oncol       Date:  2016-06       Impact factor: 2.339

2.  An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.

Authors:  Ganesh Raghu; Harold R Collard; Jim J Egan; Fernando J Martinez; Juergen Behr; Kevin K Brown; Thomas V Colby; Jean-François Cordier; Kevin R Flaherty; Joseph A Lasky; David A Lynch; Jay H Ryu; Jeffrey J Swigris; Athol U Wells; Julio Ancochea; Demosthenes Bouros; Carlos Carvalho; Ulrich Costabel; Masahito Ebina; David M Hansell; Takeshi Johkoh; Dong Soon Kim; Talmadge E King; Yasuhiro Kondoh; Jeffrey Myers; Nestor L Müller; Andrew G Nicholson; Luca Richeldi; Moisés Selman; Rosalind F Dudden; Barbara S Griss; Shandra L Protzko; Holger J Schünemann
Journal:  Am J Respir Crit Care Med       Date:  2011-03-15       Impact factor: 21.405

3.  Pulmonary carcinomas with pleomorphic, sarcomatoid, or sarcomatous elements: a clinicopathologic and immunohistochemical study of 75 cases.

Authors:  Giulio Rossi; Alberto Cavazza; Nathalie Sturm; Mario Migaldi; Nicola Facciolongo; Lucia Longo; Antonio Maiorana; Elisabeth Brambilla
Journal:  Am J Surg Pathol       Date:  2003-03       Impact factor: 6.394

4.  Postoperative morbidity, mortality, and survival in lung cancer associated with idiopathic pulmonary fibrosis.

Authors:  Hidenori Kawasaki; Kanji Nagai; Junji Yoshida; Mitsuyo Nishimura; Yutaka Nishiwaki
Journal:  J Surg Oncol       Date:  2002-09       Impact factor: 3.454

  4 in total
  1 in total

1.  MET exon 14 skipping mutation, amplification and overexpression in pulmonary sarcomatoid carcinoma: A multi-center study.

Authors:  Xue-Wen Liu; Xin-Ru Chen; Yu-Ming Rong; Ning Lyu; Chun-Wei Xu; Fang Wang; Wen-Yong Sun; San-Gao Fang; Jing-Ping Yuan; Hui-Juan Wang; Wen-Xian Wang; Wen-Bin Huang; Jian-Ping Xu; Zhen-Ying Yue; Li-Kun Chen
Journal:  Transl Oncol       Date:  2020-09-10       Impact factor: 4.243

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.